-
-
-
-
-
-
-
Corcept Therapeutics (CORT) PT Raised to $100 at Canaccord Genuity
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
-
-
-
-
-
-
-
Corcept to present ROSELLA trial data on ovarian cancer at ESMO 2025
-
-
-
-
-
-
-
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
-
-
-
-
-
15,603 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

